You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pharmacokinetics of adducts in human

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Health, Reactive Carbonyl Species, Polyphenols Trial in Kannapolis (Soymilk, green tea, or blueberry, Control group)

Recruiting
  • Human Health
  • +2 more
  • Soymilk, green tea, or blueberry
  • Control group
  • Kannapolis, North Carolina
    North Carolina Agriculture and Technical State University
Mar 6, 2023

Cystic Fibrosis Trial (VX-828, Placebo, Itraconazole)

Not yet recruiting
  • Cystic Fibrosis
  • (no location specified)
Nov 23, 2023

Male Contraception Trial (YCT-529, YCT-529 Placebo)

Not yet recruiting
  • Male Contraception
  • (no location specified)
Oct 16, 2023

Healthy Volunteers, Overweight Trial in Nottingham (GUB014295, GUB014295-PLACEBO)

Recruiting
  • Healthy Volunteers
  • Overweight
  • Nottingham, United Kingdom
    Quotient Sciences
Nov 23, 2023

Malaria Trial in Baltimore (MAM01, Placebo)

Not yet recruiting
  • Malaria
  • MAM01
  • Placebo
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, 685 W. Baltimo
May 26, 2023

Healthy Trial in Lincoln (CEL383, Placebo)

Recruiting
  • Healthy
  • Lincoln, Nebraska
    Celerion
Jun 5, 2023

Complement Deficiencies Trial (CSL040, Placebo)

Not yet recruiting
  • Complement Deficiencies
  • (no location specified)
Jul 6, 2023

Hiv Trial (LP-98 injection)

Not yet recruiting
  • Hiv
  • LP-98 injection
  • (no location specified)
Jun 27, 2023

Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)

Not yet recruiting
  • Advanced Solid Tumors
  • Recombinant human IL-21 oncolytic vaccinia virus injection
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 21, 2023

Alpha-1 Antitrypsin Deficiency Trial (VX-668, Placebo)

Not yet recruiting
  • Alpha-1 Antitrypsin Deficiency
  • (no location specified)
Feb 3, 2023

Systemic Lupus Erythematosus Trial (RO7507062, Tocilizumab)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
Apr 19, 2023

Healthy Subjects Trial in SEoul (C1K, Placebo)

Recruiting
  • Healthy Subjects
  • SEoul, Korea, Republic of
    Seoul National University Clinical Trial Center
Aug 3, 2023

Autoimmune Diseases, Multiple Sclerosis Trial in Amman (LPX-TI641)

Not yet recruiting
  • Autoimmune Diseases
  • Multiple Sclerosis
  • Amman, Jordan
    Triumpharma
May 11, 2023

Alopecia Areata Trial in Randwick (OR-101 (Single ascending dose), OR-101 (Food effect), OR-101 (Multiple ascending dose))

Not yet recruiting
  • Alopecia Areata
  • OR-101 (Single ascending dose)
  • +3 more
  • Randwick, New South Wales, Australia
    SCIENTIA Clinical Research Ltd
Sep 13, 2023

Healthy Volunteers, Mild to Moderate Psoriasis Trial in Manchester (Placebo, AX-202)

Recruiting
  • Healthy Volunteers
  • Mild to Moderate Psoriasis
  • Placebo
  • AX-202
  • Manchester, Wythenshawe, United Kingdom
    Medicines Evaluation Unit
Jul 19, 2023

Psoriasis Trial in Shanghai (HS-10374 tablets, HS-10374-matched tablets)

Completed
  • Psoriasis
  • HS-10374 tablets
  • HS-10374-matched placebo tablets
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Sep 5, 2023

Advanced Solid Tumors Trial (VVD-130037)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Jul 12, 2023

Glucocorticoids Toxicity, COVID-19, Infectious Disease Trial in Bangalore (101-PGC-005)

Active, not recruiting
  • Glucocorticoids Toxicity
  • +3 more
  • Bangalore, Karnataka, India
    ICBio Clinical Research Pvt. Ltd.
Dec 13, 2022

Still's Disease, Adult-Onset Trial in Adelaide (APB-R3, Placebo)

Not yet recruiting
  • Still's Disease, Adult-Onset
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jan 27, 2023

Healthy Volunteers Trial (EDI048, Placebo)

Recruiting
  • Healthy Volunteers
  • Mere Way, Nottingham, United Kingdom
    Novartis Investigative Site
Aug 23, 2022

Alpha 1-Antitrypsin Deficiency Trial in Tempe (VX-634, Placebo)

Recruiting
  • Alpha 1-Antitrypsin Deficiency
  • Tempe, Arizona
    Celerion - Tempe
Nov 9, 2022

Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole

Completed
  • Drug-drug Interaction Study
  • SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Nov 20, 2023

PTSD, Alzheimer, Brain Diseases Trial in Liège (Fluoroethylnormemantine (FENM))

Not yet recruiting
  • PTSD
  • +5 more
  • Fluoroethylnormemantine (FENM)
  • Liège, Belgium
    CHU of Liège - Clinical Pharmacology Unit
Jun 23, 2023

IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)

Recruiting
  • IgA Nephropathy
  • Focal Segmental Glomerulosclerosis
  • HS-10390 tablet
  • Placebo tablet
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Affiliated to Southeast University
Jul 12, 2023

HIV-1, Human Immunodeficiency Virus 1, Immunodeficiency Virus Type 1, Human Trial (MK-8510)

Not yet recruiting
  • HIV-1
  • +3 more
  • (no location specified)
Jan 17, 2023